Dashboard
Manage Tickers

JANX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-maintains-overweight-on-janux-therapeutics-raises-price-target-to-48
Barclays Maintains Overweight on Janux The...
11/07/2025 15:31:06

Barclays analyst Etzer Darout maintains Janux Therapeutics (NASDAQ:JANX) with a Overweight and raises the price target from ...

janux-therapeutics-q3-eps-039-beats-060-estimate-sales-10000m-beat-2929m-estimate
Janux Therapeutics Q3 EPS $(0.39) Beats $(...
11/06/2025 22:15:39

Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(...

watching-janux-therapeutics-shares-move-higher-traders-circulate-unconfirmed-rumor-that-co-is-seeing-ma-interest
Watching Janux Therapeutics; Shares Move H...
10/28/2025 13:57:53

barclays-initiates-coverage-on-janux-therapeutics-with-overweight-rating-announces-price-target-of-47
Barclays Initiates Coverage On Janux Thera...
09/17/2025 10:51:07

Barclays analyst Etzer Darout initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Overweight rating and announces ...

truist-securities-initiates-coverage-on-janux-therapeutics-with-buy-rating-announces-price-target-of-100
Truist Securities Initiates Coverage On Ja...
09/10/2025 13:19:21

Truist Securities analyst Asthika Goonewardene initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and ...

stifel-reinstates-buy-on-janux-therapeutics-announces-45-price-target
Stifel Reinstates Buy on Janux Therapeutic...
09/10/2025 12:32:25

Stifel analyst Bradley Canino reinstates Janux Therapeutics (NASDAQ:JANX) with a Buy and announces $45 price target.

guggenheim-initiates-coverage-on-janux-therapeutics-with-buy-rating-announces-price-target-of-72
Guggenheim Initiates Coverage On Janux The...
09/04/2025 14:01:45

Guggenheim analyst Brad Canino initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price ...

piper-sandler-initiates-coverage-on-janux-therapeutics-with-overweight-rating-announces-price-target-of-42
Piper Sandler Initiates Coverage On Janux ...
08/19/2025 12:14:30

Piper Sandler analyst Kelsey Goodwin initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Overweight rating and ann...

janux-therapeutics-q2-eps-055-misses-049-estimate
Janux Therapeutics Q2 EPS $(0.55) Misses $...
08/07/2025 20:46:59

Core News & Articles
Janux Therapeutics Announces The Dosing Of...
08/05/2025 20:44:54

Janux Therapeutics, Inc. (NASDAQ:JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel...

janux-therapeutics-showcases-advancements-in-tractr-tracir-and-arm-platforms-ahead-of-2026-trials-at-rd-day-webcast
Janux Therapeutics Showcases Advancements ...
07/24/2025 20:28:01

PSMA-TRACIr designed to be combined with potentially best-in-treatment asset, JANX007, and provide CD28 co-stimulation to furth...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
07/15/2025 17:35:24

this-harrow-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday
This Harrow Analyst Begins Coverage On A B...
07/11/2025 16:01:42

raymond-james-initiates-coverage-on-janux-therapeutics-with-outperform-rating-announces-price-target-of-65
Raymond James Initiates Coverage On Janux ...
07/11/2025 13:03:20

Raymond James analyst Sean McCutcheon initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Outperform rating and an...

janux-therapeutics-q1-eps-038-beats-041-estimate
Janux Therapeutics Q1 EPS $(0.38) Beats $(...
05/08/2025 20:15:37

Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(...

janux-therapeutics-initiates-phase-1b-expansion-studies-in-ongoing-engager-psma-01-trial
Janux Therapeutics Initiates Phase 1b Expa...
05/05/2025 12:37:36

Phase 1b expansion study initiated in taxane-naïve mCRPC patientsUpdated data from Phase 1a dose escalation support initiation ...

hc-wainwright--co-reiterates-buy-on-janux-therapeutics-maintains-70-price-target
HC Wainwright & Co. Reiterates Buy on Janu...
03/03/2025 11:48:23

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Janux Therapeutics (NASDAQ:JANX) with a Buy and maintains ...

scotiabank-maintains-sector-perform-on-janux-therapeutics-lowers-price-target-to-41
Scotiabank Maintains Sector Perform on Jan...
02/28/2025 23:36:38

Scotiabank analyst George Farmer maintains Janux Therapeutics (NASDAQ:JANX) with a Sector Perform and lowers the price targe...

janux-therapeutics-q4-2024-gaap-eps-036-beats-047-estimate
Janux Therapeutics Q4 2024 GAAP EPS $(0.36...
02/27/2025 21:34:25

Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(...

navigating-10-analyst-ratings-for-janux-therapeutics
Navigating 10 Analyst Ratings For Janux Th...
12/11/2024 20:01:05

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION